Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials

Published:2013-04 Issue:1 Volume:165 Page:17-24
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Khatib Rasha,Joseph Phillip,Briel Matthias,Yusuf Salim,Healey Jeff

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

2. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis;Healey;J Am Coll Cardiol,2005

3. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis;Huang;Eur J Clin Invest,2011

4. Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study;Wachtell;J Am Coll Cardiol,2005

5. Eplerenone and atrial fibrillation in mild systolic heart failure – results from the eplerenone in mild patients hospitalization and SurvIval study in heart failure (EMPHASIS-HF) study;Swedberg;J Am Coll Cardiol,2012

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of mineralocorticoid receptor antagonists on new-onset or recurrent atrial fibrillation: a Bayesian and frequentist network meta-analysis of randomized trials;Current Problems in Cardiology;2024-09

2. Meta-analysis of renin angiotensin aldosterone modulators mitigating Atrial Fibrillation risk in hypertensive patients;The American Journal of the Medical Sciences;2024-07

3. Pathophysiology and clinical relevance of atrial myopathy;Basic Research in Cardiology;2024-03-12

4. Ibrutinib-induced pulmonary angiotensin-converting enzyme activation promotes atrial fibrillation in rats;iScience;2024-02

5. Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials;European Heart Journal;2024-01-09